Sullivan Christopher Ryan Insider Trading Activity

Corporate InsiderCFO · CIK 1810417

12

Total trades

$1.9M

Total volume

May 7, 2026

Last activity

AVTX

Avalo Therapeutics, Inc.

Sullivan Christopher Ryan has been net-selling over the last 12 months with 0 purchases and 12 sales across 1 company.

AVTX is the most-traded position with 12 trades. The largest single transaction was a sale of AVTX for $449K on May 7, 2026.

Performance Scorecard

Forward stock performance after each transaction by Sullivan Christopher Ryan. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days—+24.9%83%12
90 days————
120 days————

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

AVTX · Avalo Therapeutics, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when Sullivan Christopher Ryan bought and sold AVTX.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEROLE
May 7, 2026AVTXSell18,606$24.12$449KCFO
May 6, 2026AVTXSell13,834$18.55$257KCFO
May 6, 2026AVTXSell12,347$19.28$238KCFO
May 6, 2026AVTXSell9,219$21.37$197KCFO
May 6, 2026AVTXSell8,900$22.57$201KCFO
May 6, 2026AVTXSell2,700$20.76$56KCFO
Apr 30, 2026AVTXSell8,457$13.23$112KCFO
Apr 29, 2026AVTXSell8,458$13.09$111KCFO
Apr 2, 2026AVTXSell6,200$17.02$106KCFO
Apr 2, 2026AVTXSell1,780$17.57$31KCFO
Apr 1, 2026AVTXSell500$15.86$8KCFO
Apr 1, 2026AVTXSell7,479$16.83$126KCFO

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
AVTXAvalo Therapeutics, Inc.12$1.9M

Other insiders at Avalo Therapeutics, Inc.

2 other tracked filers at AVTX.

Doyle Mittie

Chief Medical Officer

10

Trades

Paul Varki

Chief Legal Officer

5

Trades